StockWatch
·
Biotechnology: Pharmaceutical Preparations
Loan & DebtSep 28, 2026, 06:20 AM

Celularity Inc. Raises $11.01M via Convertible Notes and Warrants

AI Summary

Celularity Inc. has entered into a Securities Purchase Agreement to issue up to $25.0 million in aggregate principal amount of senior secured convertible promissory notes, along with warrants to purchase shares of its Class A Common Stock. The company completed an initial closing, issuing approximately $11.01 million in notes and warrants. The notes are convertible into common stock at initial prices of $1.50 or $2.00 per share depending on the tranche, and bear interest at 10% per annum, compounding annually. As security for the notes, Celularity and its subsidiaries have granted a security interest in substantially all of their assets.

Key Highlights

  • Celularity Inc. entered into a Securities Purchase Agreement to issue up to $25.0 million in senior secured convertible promissory notes.
  • The company completed an initial closing, issuing approximately $11.01 million in notes and warrants.
  • Notes issued in the initial closing are convertible into common stock at $1.50 per share.
  • Warrants issued in the initial closing have an exercise price of $1.50 per share.
  • Notes issued in Tranche 2 will have a conversion price of $2.00 per share.
  • Notes bear interest at 10% per annum, compounding annually, maturing in 24 months.
  • In case of default, notes bear interest at 15% per annum.
  • Celularity Inc. granted a security interest in substantially all of its assets to the purchasers as collateral.